The FDA's 2022 guidance on bulk drug substances explicitly named BPC-157 as a compound that does not meet the criteria for inclusion in compounded drug preparations under Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act
Ipamorelin's fat-burning effects increase the secretion of growth hormone, that in turn affect fat metabolism, muscle preservation, and overall body composition improvement
Serving size is 2 Capsules, with 30 servings per container and $2.00 per serving
Some users experience mild nasal irritation, particularly with initial use
During the initial phase, patients who experience symptoms of fatigue, low mood, or nutrient deficiency may notice a gradual improvement after the first few sessions